Operating Profit 更改
Acadia Pharmaceuticals USD 15.21M 19.73M 2024-03
ALKERMES USD 43.31M 11.32M 2024-03
Alnylam Pharmaceuticals USD -43435000 72.97M 2024-03
Biogen USD 570M 211.1M 2024-03
BioMarin Pharmaceutical USD 78.46M 64.24M 2024-03
Bristol-Myers Squibb USD 1.51B 340M 2024-03
Corcept Therapeutics USD 29.5M 2.17M 2024-03
Cytokinetics USD -126235000 1.18M 2024-03
Eisai JPY 6.11B 710M 2023-12
Eli Lilly USD 2.74B 347.8M 2024-03
Incyte USD 91.35M 95.92M 2024-03
Intra Cellular Therapies USD -20952000 13.14M 2024-03
J&J USD 6.27B 1.45B 2024-03
Moderna USD -1266000000 1.27B 2024-03
Neurocrine Biosciences USD 105.3M 35.9M 2024-03
Pfizer USD 4.2B 10.75B 2024-03
Prothena USD -81528000 3.01M 2024-03
PTC Therapeutics USD -45553000 86.18M 2024-03
Sarepta Therapeutics USD 34.9M 83.25M 2024-03
Ultragenyx Pharmaceutical USD -165347000 43.3M 2024-03
Vertex Pharmaceuticals USD 1.22B 178.1M 2024-03



Acadia Pharmaceuticals 营业利润 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.